Literature DB >> 1704388

Airway effects of inhaled bradykinin, substance P, and neurokinin A in sheep.

W M Abraham1, A Ahmed, A Cortes, M Soler, S G Farmer, L E Baugh, S L Harbeson.   

Abstract

The effects of inhaled bradykinin (BK), substance P (SP), and neurokinin A (NKA) on pulmonary resistance and airway responsiveness to carbachol were studied in conscious allergic sheep. Inhaled BK (20 breaths, 0.1 to 5.0 mg.ml-1) caused dose-dependent increases in pulmonary resistance. Neither inhaled SP nor NKA (20 breaths, 0.1 to 1.0 mg.ml-1) produced significant bronchoconstriction in allergic sheep. However, the response to SP could be enhanced (p less than 0.05) by pretreatment with the neutral endopeptidase inhibitor, thiorphan (40 breaths, 1 mg.ml-1). Sheep that were allergic to Ascaris suum antigen were 5.9 times (p less than 0.05) more sensitive to the constrictor effects of BK than nonallergic sheep. BK-induced bronchoconstriction was blocked in a dose-dependent fashion by the BK beta 2-receptor antagonist, NPC 567 (D-arginine[hydroxyproline3,D-phenylalanine7]BK). Atropine (0.2 mg.kg-1, intravenously) and nedocromil sodium (1 mg.kg-1 in 3 ml of saline, aerosolized) significantly inhibited the BK-induced bronchoconstriction by 97% and 43%, respectively. Chlorpheniramine (2 mg.kg-1, intravenously) had no effect. NKA caused a transient increase in airway responsiveness in allergic sheep, producing a mean 1.9-fold leftward shift in dose-response curves to aerosolized carbachol (p less than 0.05). This hyperresponsiveness was not evident 24 hours after NKA challenge. Neither SP nor BK changed airway responsiveness. Thus, in allergic sheep, inhaled BK caused a more pronounced bronchoconstriction than that observed in nonallergic sheep. The bronchoconstriction was blocked by a BK-receptor antagonist and appeared to be partially mediated via cholinergic reflexes.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704388     DOI: 10.1016/0091-6749(91)90015-g

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  9 in total

1.  Heterogeneity of tachykinin receptors in the rabbit lung.

Authors:  S L Millard; J W Bloom; H I Yamamura
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

2.  Involvement of kinins in hyperresponsiveness induced by platelet activating factor in the human nasal airway.

Authors:  P J Turner; J W Dear; J C Foreman
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

3.  Role of substance P and neurokinin A in toluene diisocyanate-induced increased airway responsiveness in rabbits.

Authors:  W Marek; J J Potthast; B Marcynski; X Baur
Journal:  Lung       Date:  1996       Impact factor: 2.584

4.  Kininogen deficiency or depletion reduces enhanced pause independent of pulmonary inflammation in a house dust mite-induced murine asthma model.

Authors:  Jack Yang; Cornelis van 't Veer; Joris J T H Roelofs; Jeroen W J van Heijst; Alex F de Vos; Keith R McCrae; Alexey S Revenko; Jeff Crosby; Tom van der Poll
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

Review 5.  Nedocromil sodium. An updated review of its pharmacological properties and therapeutic efficacy in asthma.

Authors:  R N Brogden; E M Sorkin
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

6.  Effects of bradykinin receptor antagonists on antigen-induced respiratory distress, airway hyperresponsiveness and eosinophilia in guinea-pigs.

Authors:  S G Farmer; D E Wilkins; S A Meeker; E A Seeds; C P Page
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

7.  Neurokinin A-induced contraction of guinea-pig isolated trachea: potentiation by hepoxilins.

Authors:  O Laneuville; R Couture; C R Pace-Asciak
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

8.  Effects of inhaled brevetoxins in allergic airways: toxin-allergen interactions and pharmacologic intervention.

Authors:  William M Abraham; Andrea J Bourdelais; Ashfaq Ahmed; Irakli Serebriakov; Daniel G Baden
Journal:  Environ Health Perspect       Date:  2005-05       Impact factor: 9.031

Review 9.  Hyperresponsiveness in the human nasal airway: new targets for the treatment of allergic airway disease.

Authors:  P J Turner; J C Foreman
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.